Personalizing Care for the Evolving Spectrum of NSCLC: Identifying Novel Biologic, Genetic, and Molecular Targets

4. 6. 2010 - 4. 6. 2010, Hilton Chicago, Chicago, Illinois, USA


Program sympózia

6:00 pm
Registration and Dinner

6:30 pm
Welcome and introduction
Giorgio Scagliotti, MD, PhD

6:40 pm
Overview of emerging biologic, genetic, and molecular targets in NSCLC
Tony Mok, MD

6:55 pm
Is histology a prognostic and predictive marker in NSCLC?
Giorgio Scagliotti, MD, PhD

7:10 pm
Does EGFR only matter in Asia?
Suresh S. Ramalingam, MD

7:30 pm
Targeting novel molecular markers in NSCLC
Roy Herbst, MD, PhD

7:50 pm
Lung cancer in non-smokers: A truly different disease?
Jeffrey A. Engelman, MD, PhD

8:10 pm
Practical clinical guidelines for utilization of biologic, genetic, and molecular markers Panel Discussion

8:30 pm



  • Sdílejte na:
    • Facebook
    • Twitter
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live